Since PP2 and dasatinib efficiently blocked activation of BCR-associated LYN in MCL cells, we next evaluated the impact of these compounds on JNK phosphorylation, EGR-1 expression and on cell survival upon BCR engagement. The gene discussed is EGR1; the disease is mantle cell lymphoma.